1. Home
  2. SLNO vs LMND Comparison

SLNO vs LMND Comparison

Compare SLNO & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • LMND
  • Stock Information
  • Founded
  • SLNO 1999
  • LMND 2015
  • Country
  • SLNO United States
  • LMND United States
  • Employees
  • SLNO N/A
  • LMND N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LMND Property-Casualty Insurers
  • Sector
  • SLNO Health Care
  • LMND Finance
  • Exchange
  • SLNO Nasdaq
  • LMND Nasdaq
  • Market Cap
  • SLNO 3.7B
  • LMND 3.9B
  • IPO Year
  • SLNO 2014
  • LMND 2020
  • Fundamental
  • Price
  • SLNO $46.98
  • LMND $74.95
  • Analyst Decision
  • SLNO Strong Buy
  • LMND Hold
  • Analyst Count
  • SLNO 9
  • LMND 10
  • Target Price
  • SLNO $114.89
  • LMND $40.10
  • AVG Volume (30 Days)
  • SLNO 2.2M
  • LMND 3.1M
  • Earning Date
  • SLNO 11-04-2025
  • LMND 11-05-2025
  • Dividend Yield
  • SLNO N/A
  • LMND N/A
  • EPS Growth
  • SLNO N/A
  • LMND N/A
  • EPS
  • SLNO N/A
  • LMND N/A
  • Revenue
  • SLNO $98,675,000.00
  • LMND $658,300,000.00
  • Revenue This Year
  • SLNO N/A
  • LMND $38.27
  • Revenue Next Year
  • SLNO $181.30
  • LMND $63.05
  • P/E Ratio
  • SLNO N/A
  • LMND N/A
  • Revenue Growth
  • SLNO N/A
  • LMND 33.66
  • 52 Week Low
  • SLNO $41.50
  • LMND $24.31
  • 52 Week High
  • SLNO $90.32
  • LMND $81.90
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 31.94
  • LMND 68.75
  • Support Level
  • SLNO $66.12
  • LMND $58.26
  • Resistance Level
  • SLNO $69.99
  • LMND $81.90
  • Average True Range (ATR)
  • SLNO 3.71
  • LMND 4.61
  • MACD
  • SLNO -2.47
  • LMND 2.41
  • Stochastic Oscillator
  • SLNO 18.57
  • LMND 78.34

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.

Share on Social Networks: